ESC Premium Access

Poster session 7 - Blood markers and reperfusion

Event: ESC CONGRESS 2016
Topic: Miscellaneous
Session type: Poster Session
Date: 30 August 2016

Congress Session

20 presentations in this session

Effect of poor glycemic control and systemic inflammation on cardiovascular outcomes in patients with coronary artery disease undergoing percutaneous coronary intervention

Speaker: Doctor G. Giustino (New York, US)
Thumbnail

Prognostic implications of admission anemia in patients undergoing primary percutaneous coronary intervention

Speaker: Assistant Professor D. Matic (Belgrade, RS)
Thumbnail

Hydration volume and its association with short- and long-term major adverse clinical events in patients with chronic heart failure after exposure to contrast media

Speaker: Doctor H. Li (Guangzhou, CN)
Thumbnail

Impact of diabetes mellitus and contrast-induced acute kidney injury on 3-year mortality in STEMI patients undergoing primary PCI

Speaker: Doctor D. Milasinovic (Belgrade, RS)
Thumbnail

Higher circulating osteopontin specifically predicts cardiovascular death while urinary osteopontin predicts kidney disease progression

Speaker: Mr T. Rudholm Feldreich (Falun, SE)
Thumbnail

Creatinine measurements and myocardial revascularization rates on patients with slightly elevated hs-cTnT levels

Speaker: Professor M. Vorpahl (Wuppertal, DE)
Thumbnail

Successful reperfusion is associated with lower levels of markers of myocardial damage and dysfunction in ST-elevation but not in non-ST-elevation myocardial infarction: insights from the PLATO trial

Speaker: Associate Professor C. Varenhorst (Uppsala, SE)
Thumbnail

Different estimates of mean arterial pressure by using different formulas and their relation with target organ damage: a single-center study of 1878 individuals

Speaker: Doctor T. Papaioannou (Athens, GR)
Thumbnail

The association between serum cathepsin l and mortality in older adults

Speaker: Mr T. Rudholm Feldreich (Falun, SE)
Thumbnail

Differential predictive value of low testosterone concentrations for incident atrial fibrillation and or ischemic stroke in men and women: results from the FINRISK study

Speaker: Doctor M. Karakas (Hamburg, DE)
Thumbnail

20 speakers from this session

Doctor Gennaro Giustino

Mount Sinai Hospital, New York (United States of America)
0 follower

Assistant Professor Dragan Matic

Clinical Center of Serbia, Institute for Cardiovascular Disease, Emergency Hospital, Belgrade (Serbia)
0 follower

Doctor Hualong Li

Guangdong General Hospital Guangdong Cardiovascular Institute, Guangzhou (China)
0 follower

Doctor Dejan Milasinovic

Clinical Center of Serbia, Clinic for Cardiology, Belgrade (Serbia)
0 follower

Mr Tobias Rudholm Feldreich

Dalarna University, Falun (Sweden)
0 follower

Professor Marc Michael Vorpahl

Helios Clinic Wuppertal, Wuppertal (Germany)
0 follower

Associate Professor Christoph Varenhorst

Uppsala University, Uppsala (Sweden)
0 follower

Doctor Theodore Papaioannou

National & Kapodistrian University of Athens, Athens (Greece)
0 follower

Mr Tobias Rudholm Feldreich

Dalarna University, Falun (Sweden)
0 follower

Doctor Mahir Karakas

The University Medical Center Hamburg-Eppendorf, Hamburg (Germany)
3 presentations
0 follower

Associate Professor Jae-Sik Jang

Busan Paik Hospital, Busan (Korea (Republic of))
0 follower

Associate Professor Young-Hyo Lim

Hanyang university medical center, Seoul (Korea (Republic of))
0 follower

Doctor Jun Shitara

Juntendo University Shizuoka Hospital, Izunokuni (Japan)
0 follower

Doctor Takashi Unoki

Saiseikai Kumamoto Hospital, Kumamoto (Japan)
0 follower

Doctor Masanori Shiba

Nissan Tamagawa hospital, Tokyo (Japan)
0 follower

Associate Professor Hyung Joon Joo

Korea University Anam Hospital, Seoul (Korea (Republic of))
0 follower

Doctor Violeta Pavlovic

Clinical Center of Serbia, Belgrade (Serbia)
0 follower

Associate Professor Tomasz Rakowski

Jagiellonian University Medical College, Krakow (Poland)
0 follower

Doctor Ioannis-Georgios Kanakakis

Alexandra University Hospital, Athens (Greece)
2 presentations
0 follower

Doctor Chang Wei-Ting

Chi-Mei Medical Center, Tainan (Taiwan)
0 follower

This platform is supported by

logo Novo Nordisk